Cisgender Female Patients Who Start on Long Acting Cabotegravir for PrEP
Condition(s):HivLast Updated:February 5, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):HivLast Updated:February 5, 2024Recruiting
Condition(s):HIV Prevention; Pre-exposure ProphylaxisLast Updated:December 21, 2021Unknown status
Condition(s):HIV Infection; Sexually Transmitted Infections; Pre-exposure Prophylaxis; Systems NavigationLast Updated:February 20, 2024Not yet recruiting
Condition(s):Pre-Exposure Prophylaxis of HIV InfectionLast Updated:February 23, 2024Recruiting
Condition(s):HIV Infections; Hiv; Sexually Transmitted Infections (Not HIV or Hepatitis); Sexually Transmitted Diseases; Sexual Behavior; Risk ReductionLast Updated:May 26, 2023Recruiting
Condition(s):Preexposure Prophylaxis; HIV InfectionsLast Updated:January 12, 2024Enrolling by invitation
Condition(s):HIV; PrEPLast Updated:February 29, 2024Recruiting
Condition(s):HIV InfectionsLast Updated:February 22, 2024Completed
Condition(s):HIV InfectionsLast Updated:January 5, 2024Active, not recruiting
Condition(s):HIV-I; Human Immunodeficiency Virus Type 1; ProphylaxisLast Updated:October 17, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.